Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest research
Our research can still be accessed for free under MIFID II.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax enhanced research
- VCT
- EIS
- SEIS
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
City of London Investment Group
Financials
FUM, profits and dividend all moving on up
By
Dr Brian Moretta
22 Jan 2018
Avacta Group plc
Life Sciences
Gene delivery collaboration
By
Dr Martin Hall
22 Jan 2018
genedrive Plc
Life Sciences
Hepatitis C point-of-care diagnostic launched
By
Dr Martin Hall
18 Jan 2018
ValiRx
Life Sciences
VAL401 improves quality of life
By
Dr Dorothea Hill
18 Jan 2018
1pm Plc
Financials
Interim results: delivering value-added strategy
By
Mark Thomas
16 Jan 2018
Avacta Group plc
Life Sciences
Affimer Drug Conjugates a reality
By
Dr Martin Hall
15 Jan 2018
Building & Construction
UK Housebuilding Book in 2017; e il futuro
By
Tony Williams
12 Jan 2018
Alliance Pharma Plc
Life Sciences
Acquisitions to boost growth prospects
By
Dr Martin Hall
11 Jan 2018
Life Sciences
Hardman Healthcare Index: 2017 – another year of outperformance
By
Dr Martin Hall
11 Jan 2018
Burford Capital
Financials
Continued evidence of growth
By
Dr Brian Moretta
10 Jan 2018
Primary Health Properties
Investment Companies
All the more reason to anticipate stable growth
By
Mike Foster
10 Jan 2018
Prev
1
...
41
42
43
44
45
...
52
Next
